Studies describe the role of neoantigens in cancer immunotoxicity due to their involvement in T-cell responses mediated by antigen-presenting cells (APCs), dendritic cells [35] which present antigen peptides to cytotoxic T-cells (CD8+ cells) via the major histocompatibility complex (MHC). This evidence concerns the gene CD8A and cancer.